Table 1. Demographic and characteristics of studies included in the meta-analysis.
Reference (first author) | Country | Parients No | Age | Gender (male%) | Newcastle-Ottawa score | |||||
---|---|---|---|---|---|---|---|---|---|---|
PTX | CTRL | PTX | CTRL | PTX | CTRL | Selection | Comparability | Exposure | ||
Ivarsson etal. 2015 [23] | Sweden | 423 | 1234 | 55.2 | 56 | 48.2 | 50.1 | *** | ** | ** |
Komaba et al. 2015 [17] | Japan | 4428 | 4428 | 59.1 ± 11.6 | 59.3±12.3 | 55.8 | 55.7 | *** | ** | *** |
Conzo et al. 2013 [20] | Italy | 30 | 20 | 51.5±10.89 | 55±11.2 | 26.7 | 40 | *** | * | * |
Sharma et al. 2013 [51] | US | 150 | 1044 | 42.1 | 42.2 | 46.7 | 46.7 | *** | ** | ** |
Goldstein et al 2013 [21] | Brazil | 123 | 128 | 46 | 50 | 46.3 | 44.5 | *** | * | ** |
Iwamoto et al 2012 [16] | Japan | 88 | 88 | 60.6±8.4 | 60.5±8.4 | 53.4 | 53.4 | *** | ** | ** |
Kestenbaun et al. 2004 [24] | US | 4558 | 4558 | 47.6 | 47.6 | 42.5 | 42.5 | *** | ** | * |
Trombetti et al. 2007 [44] | Switzerland | 40 | 80 | 42.6 | 55 | 45 | 51 | *** | ** | ** |
Ho LC et al. 2016 [45] | Taiwan | 998 | 998 | 54.7 | 55 | 42.9 | 42.5 | *** | ** | *** |
Moldovan et al. 2015 [22] | Romania | 26 | 26 | 51.62±9.92 | 49.65±11.49 | 53.84 | 23.07 | *** | * | ** |
Li-Wedong et al 2016 [46] | China | 53 | 92 | 63.1±13.8 | 53.8±15 | 56.6 | 70.6 | *** | * | * |
Costa-Hong et al 2007 [18] | Brazil | 50 | 68 | 52 | 59 | 43±10 | 45±12 | ** | ** | * |
Dussol B et al 2007[47] | France | 19 | 32 | N/A | N/A | N/A | N/A | ** | ** | * |
Ma T-L et al 2015[48] | Taiwan | 60 | 161 | N/A | N/A | N/A | N/A | ** | ** | * |
Lin H-C 2014[19] | Taiwan | 30 | 23 | 53.3 ± 13.3 | 53.4 ±13.9 | 43 | 61 | *** | ** | * |
Abbreviations: PTX-parathyroidectomy, CTRL- control
*- Stars awarded for each quality item (Newcastle-Ottawa scale). For each domain, either a "star" or "no star" is assigned, with a "star" indicating that study design element was considered adequate and less likely to introduce bias. For Selection (of the exposed cohort, of the non-exposed cohort, ascertainment of exposure and outcome of interest) a maximum of four stars may be assigned. A maximum of two stars can be given for Comparability and a maximum of 3 stars can be given for Exposure (assessment of outcome, length of follow-up and adequacy offollow-up). A study could receive a maximum of nine stars.